First-year premiums (FYPs) of foreign currency-denominated life insurance policies fell 6 percent to NT$58.73 billion (US$1.94 billion) in January from NT$62.4 billion a year earlier, Financial Supervisory Commission data showed.
Despite the industry trend, FYPs of US dollar-denominated policies increased 9 percent year-on-year to US$1.83 billion, the data showed, with FYPs of traditional life insurance policies increasing 16 percent to US$1.41 billion, while those of investment-linked policies decreased 9 percent to US$416 million.
FYPs of US dollar-denominated policies totaled US$14.797 billion for the whole of last year, down 14 percent from 2018, the data showed.
The increase in January showed that the policies had regained the favor of local investors, as they offer better investment returns and higher bonuses than New Taiwan dollar-denominated policies, the commission said.
However, the US Federal Reserve’s unexpected interest rate cut of 1.5 percentage points earlier this month would make it difficult for life insurers to maintain the same investment returns and that could lead to lower sales of US dollar-denominated policies, the commission added.
FYPs of yuan-denominated policies shrank 65 percent year-on-year to 328 million yuan (US$46.2 million) in January — a 68 percent slump in investment-linked policies and a 17 percent fall in traditional life insurance policies, the data showed.
FYPs of yuan products for the whole of last year fell 43 percent to 5.82 billion yuan and the continued decrease was likely due to the volatility of Chinese financial markets amid the COVID-19 pandemic and the yuan’s weakness against the greenback, the commission said.
FYPs of policies denominated in Australian dollars fell 49 percent year-on-year to A$79 million (US$48.5 million) in January, including a 60 percent fall of FYPs of index-linked policies and a 43 percent decline in FYPs of traditional life insurance policies, the data showed.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained